2025 annual financial data

Neuphoria Therapeutics Inc. 2025 Operating margin

Neuphoria Therapeutics Inc. 2025 operating margin with verified reported values.

Direct answer

Operating margin was -7.21%.

Operating income was -1,129,091 USD and net income was -369,632 USD.
Operating cash flow was 77,229,000 USD.

Get free Neuphoria Therapeutics Inc. email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
15,649,448 USD
Operating income
-1,129,091 USD
Net income
-369,632 USD
Operating cash flow
77,229,000 USD